<--- Back to Details
First PageDocument Content
Biology / Animal testing / Bioethics / Alternatives to animal testing / Medical research / Biotechnology / Stem cells / Federal Department of Home Affairs / Embryonic stem cell / Regenerative medicine / In vitro / Model organism
Date: 2015-06-19 04:08:28
Biology
Animal testing
Bioethics
Alternatives to animal testing
Medical research
Biotechnology
Stem cells
Federal Department of Home Affairs
Embryonic stem cell
Regenerative medicine
In vitro
Model organism

3R Research Foundation Switzerland Annual Report 2014

Add to Reading List

Source URL: www.forschung3r.ch

Download Document from Source Website

File Size: 113,72 KB

Share Document on Facebook

Similar Documents

China Regenerative Medicine International Limited 中國再生醫學國際有限公司 Incorporated in the Cayman Islands with limited liability 於開曼群島註冊成立之有限公司 Stock Code 股份代號:8158

DocID: 1vnZo - View Document

[For immediate release] [Press Release] China Regenerative Medicine International Limited (Stock Code: 8158.HK)

DocID: 1vlMf - View Document

Centre for Cell Therapy and Regenerative Medicine 6th Margaret River Region Forum and 9th ASSCR Annual Scientific Meeting Stem Cells: Fundamental Biology and Clinical Translation

DocID: 1v4Rh - View Document

May 24, 2018 CollPlant Reports First Quarter 2018 Financial Results and Provides Business Update NESS ZIONA, Israel, May 24, 2018 /PRNewswire/ -CollPlant (NASDAQ: CLGN) (TASE: CLGN), a regenerative medicine company util

DocID: 1uYu4 - View Document

China Regenerative Medicine International Limited 中國再生醫學國際有限公司 Annual Report 年報

DocID: 1uNPZ - View Document